Breast Cancer Biomarker Guidelines Include Genomics
This article was originally published in The Pink Sheet Daily
Breast cancer biomarker guidelines include genomics – The American Society of Clinical Oncology updated its seven-year old recommendations for the use of breast cancer biomarkers, recommending for the first time a multiparameter genomic test for informing chemotherapy treatment.
You may also be interested in...
Tom McLain tells how the new MCIT policy from the US Medicare agency – and winning support from Congress – will guarantee Medicare coverage for his company’s product, an artificial intelligence-enabled in vitro diagnostic platform.
Patient Safety Advocate Raises Alarm Over HHS/FDA Push That Could Exempt 80+ Devices From Regulation
National Center for Health Research president Diana Zuckerman is concerned about a new joint notice from the US HHS and the FDA designed to deregulate a slew of devices and tests.
On this week’s podcast we talk about outgoing US FDA chief Stephen Hahn and the role he wants to play beyond 20 January, as an ex-commissioner. We also discuss the US enforcement landscape around COVID-19-related products and how it’s still taking shape.